Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Waldner

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
AIDS (London, England)|July 1, 1994
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patientsP Chavanet, J Lopez, M Grappin, et al.
HIV Medicine|March 14, 2007
Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemiaM Duong, J P Dumas, M Buisson, et al.
Presse Medicale (Paris, France : 1983)|July 7, 1990
[Endocrine abnormalities in HIV infections]B Verges, P Chavanet, J Desgres, et al.
Medecine Et Maladies Infectieuses|March 12, 2014
Informal consultation at a teaching hospital infectious diseases departmentC Rameau, S Mahy, A-L Simonet Lamm, et al.
Journal of Clinical Apheresis|January 1, 1990
Acyclovir pharmacokinetics in plasmapheresisP Y Chavanet, F Bailly, C Mousson, et al.
Minerva Medica|October 28, 2015
Rehabilitation procedures in the management of gait disorders in the elderlyM Gandolfi, E Dimitrova, F Nicolli, et al.
Leukemia & Lymphoma|November 1, 1992
Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemiaT Petrella, F Bailly, F Mugneret, et al.
Pathologie-Biologie|May 1, 1992
[Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy]P Chavanet, N Charlier, A Brenet, et al.
The Journal of Infectious Diseases|August 1, 1992
High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitisP Chavanet, B Bonnotte, M Guiguet, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
AIDS (London, England)|July 1, 1994
Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patientsP Chavanet, J Lopez, M Grappin, et al.
HIV Medicine|March 14, 2007
Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemiaM Duong, J P Dumas, M Buisson, et al.
Presse Medicale (Paris, France : 1983)|July 7, 1990
[Endocrine abnormalities in HIV infections]B Verges, P Chavanet, J Desgres, et al.
Medecine Et Maladies Infectieuses|March 12, 2014
Informal consultation at a teaching hospital infectious diseases departmentC Rameau, S Mahy, A-L Simonet Lamm, et al.
Journal of Clinical Apheresis|January 1, 1990
Acyclovir pharmacokinetics in plasmapheresisP Y Chavanet, F Bailly, C Mousson, et al.
Minerva Medica|October 28, 2015
Rehabilitation procedures in the management of gait disorders in the elderlyM Gandolfi, E Dimitrova, F Nicolli, et al.
Leukemia & Lymphoma|November 1, 1992
Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemiaT Petrella, F Bailly, F Mugneret, et al.
Pathologie-Biologie|May 1, 1992
[Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy]P Chavanet, N Charlier, A Brenet, et al.
The Journal of Infectious Diseases|August 1, 1992
High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitisP Chavanet, B Bonnotte, M Guiguet, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study GroupM Savès, F Raffi, P Clevenbergh, et al.
Pageof 5